Though granulocyte–monocyte expansion in BC and PDAC has been shown to impede tumor immune surveillance7–9, it is important to consider the role of cDC1s in orchestrating anti-tumor CD8+ T-cell responses. This evidence concerns the gene CD8A and breast cancer.